Immix Biopharma, Inc.IMMXNASDAQ
Loading
Net Income ContractionContracting
Percentile Rank17
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-23.56M
↓ 73% vs avg
Percentile
P17
Within normal range
Streak
3 yr
Consecutive declineContracting
Average
$-13.62M
Historical baseline
PeriodValueYoY Change
TTM$-23.56M-9.0%
2024$-21.61M-40.1%
2023$-15.43M-87.4%
2022$-8.23M+66.2%
2021$-24.38M-2024.3%
2020$-1.15M-18.0%
2019$-972811.00-